These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 4338965)

  • 41. [Antigenic activity of Bordetella pertussis during cultivation in liquid nutrient media].
    Miriasova LV; Moshiashvili IIa; Basnak'ian IA; Sergeev VV; Zaporozhtsev LN
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jun; (6):31-6. PubMed ID: 209647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The mechanism of the adjuvant effect of Bordetella pertussis: the substance responsible for the selective enhancement of IgE antibody production.
    Mota I; Perini A; Trindade VS
    Int Arch Allergy Appl Immunol; 1974; 47(3):425-32. PubMed ID: 4372184
    [No Abstract]   [Full Text] [Related]  

  • 43. [A comparative analysis of the effect of Bordetella pertussis preparations on a primary culture of murine peritoneal macrophages].
    Tiukavkina SIu; Moskalenko EP
    Mikrobiol Z; 1996; 58(2):58-63. PubMed ID: 8983523
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The adjuvant activity of Bordetella pertussis in mice with congenital aplasia of the thymus.
    Finger H; Hof H; Elekes E
    Z Immunitatsforsch Exp Klin Immunol; 1973 Sep; 145(5):460-6. PubMed ID: 4377483
    [No Abstract]   [Full Text] [Related]  

  • 45. Development of pertussis serological potency test. Serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model.
    van der Ark A; van Straaten-van de Kappelle I; Akkermans A; Hendriksen C; van de Donk H
    Biologicals; 1994 Sep; 22(3):233-42. PubMed ID: 7811457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjuvant principle of pertussis vaccine in the mouse.
    Pieroni RE; Levine L
    Nature; 1966 Sep; 211(5056):1419-20. PubMed ID: 4291099
    [No Abstract]   [Full Text] [Related]  

  • 47. Adjuvant and immunogenic activities of the 73kDa N-terminal alpha-domain of BrkA autotransporter and Cpn60/60kDa chaperonin of Bordetella pertussis.
    Cainelli Gebara VC; Risoléo L; Lopes AP; Ferreira VR; Quintilio W; Lépine F; Silva WD; Raw I
    Vaccine; 2007 Jan; 25(4):621-9. PubMed ID: 17011680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bordetella pertussis serotypes in Canada.
    Toma S; Lo H; Magus M
    Can Med Assoc J; 1978 Oct; 119(7):722-4. PubMed ID: 213182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disruption of Bordetella pertussis in the Ribi cell fractionator. 1. Effect of different pressures.
    Hollinger E; Wardlaw AC
    Can J Microbiol; 1971 Sep; 17(9):1169-74. PubMed ID: 4329814
    [No Abstract]   [Full Text] [Related]  

  • 50. Overcoming of endotoxin--mediated immunosuppression by Bordetella pertussis.
    Finger H; Fölmer I; Plager L; Henseling M
    Experientia; 1972 May; 28(5):562-3. PubMed ID: 4339277
    [No Abstract]   [Full Text] [Related]  

  • 51. Time relationships between injection of antigen and adjuvant. 3. Adjuvancy of Bordetella pertussis given at various times after the primary antigenic stimulus.
    Finger H; Emmerling P; Plager L
    Infect Immun; 1972 May; 5(5):783-91. PubMed ID: 4344394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Physicochemical and immunobiological properties of the dialysate antigen of Bordetella pertussis].
    Iagovkina VV; Moskalenko EP
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Dec; (12):11-5. PubMed ID: 2895557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapidity of antigenic modulation of Bordetella pertussis in modified Hornibrook medium.
    Idigbe EO; Parton R; Wardlaw AC
    J Med Microbiol; 1981 Nov; 14(4):409-18. PubMed ID: 6273564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leukocytosis-promoting factor of Bordetella pertussis. 3. Its identity with protective antigen.
    Sato Y; Arai H; Suzuki K
    Infect Immun; 1974 May; 9(5):801-10. PubMed ID: 4363229
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The reactivity of aged mice to Bordetella pertussis as an immunological adjuvant.
    Finger H; Emmerling P; Bertz R
    Gerontologia; 1971; 17(5):323-32. PubMed ID: 4339715
    [No Abstract]   [Full Text] [Related]  

  • 56. Stimulation of non-specific resistance by heterologous endotoxins and experimental immunity to Bordetella pertussis in mice.
    Iida T; Tajima M
    Immunology; 1971 Aug; 21(2):313-22. PubMed ID: 4328408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SYMPOSIUM ON RELATIONSHIP OF STRUCTURE OF MICROORGANISMS TO THEIR IMMUNOLOGICAL PROPERTIES. III. STRUCTURE AND BIOLOGICAL PROPERTIES OF SURFACE ANTIGENS FROM GRAM-NEGATIVE BACTERIA.
    MILNER KC; ANACKER RL; FUKUSHI K; HASKINS WT; LANDY M; MALMGREN B; RIBI E
    Bacteriol Rev; 1963 Dec; 27(4):352-68. PubMed ID: 14097345
    [No Abstract]   [Full Text] [Related]  

  • 58. [Immunochemical study of the antigenic structure of Bordetella genus bacteria. I. Immunoelectrophoretic analysis of the antigenic structure of different strains of Bordetella pertussis and their biological properties].
    Samsonova VS; Kolchev NV; Shed'ko NN; Kondrat'eva AM; Mamaeva EA
    Zh Mikrobiol Epidemiol Immunobiol; 1971; 48(6):17-22. PubMed ID: 4328259
    [No Abstract]   [Full Text] [Related]  

  • 59. The stability of the protective antigen and histamine-sensitizing factor of Bordetella pertussis to acid and alkali.
    Jakus CM; McClure L; Wardlaw AC
    Can J Microbiol; 1968 Feb; 14(2):147-51. PubMed ID: 4296232
    [No Abstract]   [Full Text] [Related]  

  • 60. [Action of Bordetella pertussis on the lymphatic tissue of mice. I. Increase in the spleen weight of white mice following injection of Bordetella pertussis].
    Finger H; Beneke G; Emmerling P
    Z Med Mikrobiol Immunol; 1968; 154(1):23-34. PubMed ID: 4303990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.